The EU's drug watchdog said today that it expects to decide in early October whether to approve boosters of the Pfizer/BioNTech coronavirus vaccine for all people aged over 16.
A decision on further doses of both the Pfizer and Moderna vaccines for at-risk people and the elderly is due at the same time, the European Medicines Agency (EMA) said.
Protection against the disease is shown to decrease in the months following the first jabs, the Amsterdam-based regulator's head of vaccine strategy Marco Cavaleri told a news conference. "The available data are showing that immunity against Covid-19 from initial vaccination wanes over time, and the protection from infection and symptomatic disease is decreasing in different parts of the world," Dr